Reuters logo
BRIEF-Capricor to present 6-month results from the randomized hope trial of CAP-1002
September 18, 2017 / 11:17 AM / 3 months ago

BRIEF-Capricor to present 6-month results from the randomized hope trial of CAP-1002

Sept 18 (Reuters) - Capricor Therapeutics Inc

* Capricor Therapeutics to present six-month results from the randomized hope trial of CAP-1002 in duchenne muscular dystrophy in a late breaking session of the world muscle society Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below